Click for best price
CART Cellular Immunotherapy Drug Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for CAR-T Cellular Immunotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cellular Immunotherapy Drug. This report contains market size and forecasts of CAR-T Cellular Immunotherapy Drug in global, including the following market information:
Global CAR-T Cellular Immunotherapy Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global CAR-T Cellular Immunotherapy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19-Targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR-T Cellular Immunotherapy Drug include Novartis AG, Kite Pharma, Bristol Myers Squibb and Fosun Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR-T Cellular Immunotherapy Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Cellular Immunotherapy Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global CAR-T Cellular Immunotherapy Drug Market Segment Percentages, by Type, 2022 (%)
CD19-Targeted
BCMA-Targeted
Global CAR-T Cellular Immunotherapy Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global CAR-T Cellular Immunotherapy Drug Market Segment Percentages, by Application, 2022 (%)
Multiple Myeloma
Non-Hodgkin lymphoma
Leukemia
Global CAR-T Cellular Immunotherapy Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global CAR-T Cellular Immunotherapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR-T Cellular Immunotherapy Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR-T Cellular Immunotherapy Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR-T Cellular Immunotherapy Drug, market overview.
Chapter 2: Global CAR-T Cellular Immunotherapy Drug market size in revenue.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR-T Cellular Immunotherapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
CAR-T Cellular Immunotherapy Drug Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR-T Cellular Immunotherapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Cellular Immunotherapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Cellular Immunotherapy Drug Overall Market Size
2.1 Global CAR-T Cellular Immunotherapy Drug Market Size: 2022 VS 2030
2.2 Global CAR-T Cellular Immunotherapy Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Cellular Immunotherapy Drug Players in Global Market
3.2 Top Global CAR-T Cellular Immunotherapy Drug Companies Ranked by Revenue
3.3 Global CAR-T Cellular Immunotherapy Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Cellular Immunotherapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR-T Cellular Immunotherapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Cellular Immunotherapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR-T Cellular Immunotherapy Drug Market Size Markets, 2022 & 2030
4.1.2 CD19-Targeted
4.1.3 BCMA-Targeted
4.2 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue & Forecasts
4.2.1 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2023
4.2.2 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue, 2024-2030
4.2.3 By Type - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR-T Cellular Immunotherapy Drug Market Size, 2022 & 2030
5.1.2 Multiple Myeloma
5.1.3 Non-Hodgkin lymphoma
5.1.4 Leukemia
5.2 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue & Forecasts
5.2.1 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2023
5.2.2 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue, 2024-2030
5.2.3 By Application - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CAR-T Cellular Immunotherapy Drug Market Size, 2022 & 2030
6.2 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue & Forecasts
6.2.1 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2023
6.2.2 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue, 2024-2030
6.2.3 By Region - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.3.2 US CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.3.3 Canada CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.3.4 Mexico CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.4.2 Germany CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.3 France CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.4 U.K. CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.5 Italy CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.6 Russia CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.7 Nordic Countries CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.4.8 Benelux CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.5.2 China CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.3 Japan CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.4 South Korea CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.5 Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.5.6 India CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.6.2 Brazil CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.6.3 Argentina CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030
6.7.2 Turkey CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7.3 Israel CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7.4 Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
6.7.5 UAE CAR-T Cellular Immunotherapy Drug Market Size, 2018-2030
7 CAR-T Cellular Immunotherapy Drug Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.1.4 Novartis AG CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.2.4 Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.3.4 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Fosun Pharma
7.4.1 Fosun Pharma Company Summary
7.4.2 Fosun Pharma Business Overview
7.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Major Product Offerings
7.4.4 Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue in Global Market (2018-2023)
7.4.5 Fosun Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR-T Cellular Immunotherapy Drug Market Opportunities & Trends in Global Market
Table 2. CAR-T Cellular Immunotherapy Drug Market Drivers in Global Market
Table 3. CAR-T Cellular Immunotherapy Drug Market Restraints in Global Market
Table 4. Key Players of CAR-T Cellular Immunotherapy Drug in Global Market
Table 5. Top CAR-T Cellular Immunotherapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR-T Cellular Immunotherapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR-T Cellular Immunotherapy Drug Product Type
Table 9. List of Global Tier 1 CAR-T Cellular Immunotherapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Cellular Immunotherapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR-T Cellular Immunotherapy Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2024-2030
Table 30. Novartis AG Company Summary
Table 31. Novartis AG CAR-T Cellular Immunotherapy Drug Product Offerings
Table 32. Novartis AG CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Kite Pharma Company Summary
Table 35. Kite Pharma CAR-T Cellular Immunotherapy Drug Product Offerings
Table 36. Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Kite Pharma Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product Offerings
Table 40. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. Fosun Pharma Company Summary
Table 43. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product Offerings
Table 44. Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Fosun Pharma Key News & Latest Developments
List of Figures
Figure 1. CAR-T Cellular Immunotherapy Drug Segment by Type in 2022
Figure 2. CAR-T Cellular Immunotherapy Drug Segment by Application in 2022
Figure 3. Global CAR-T Cellular Immunotherapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR-T Cellular Immunotherapy Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global CAR-T Cellular Immunotherapy Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2022
Figure 8. By Type - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 16. US CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 20. Germany CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 28. China CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 34. Brazil CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa CAR-T Cellular Immunotherapy Drug Revenue Market Share, 2018-2030
Figure 37. Turkey CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE CAR-T Cellular Immunotherapy Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis AG CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
